More evidence suggests vaccines protect against delta variant; Pfizer booster shot extends protection: Live COVID-19 updates

Business

USA TODAY 09 July, 2021 - 03:00am 18 views

Pfizer and BioNTech announced Thursday they are developing a Covid-19 booster shot intended to target the delta variant as concerns rise about the highly transmissible strain that is already the dominant form of the disease in the United States.

The companies said although they believe a third shot of their current two-dose vaccine has the potential to preserve the "highest levels" of protection against all currently known variants, including delta, they are "remaining vigilant" and developing an updated version of the vaccine.

"As seen in real world evidence released from the Israel Ministry of Health, vaccine efficacy has declined six months post-vaccination, at the same time that the Delta variant is becoming the dominate variant in the country," the companies said in a written statement.

"These findings are consistent with an ongoing analysis from the companies' Phase 3 study," they said. "That is why we have said, and we continue to believe that it is likely, based on the totality of the data we have to date, that a third dose may be needed within 6 to 12 months after full vaccination."

Clinical studies could begin as early as August, subject to regulatory approvals, the companies said.

The announcement comes the same day Olympics organizers said they are banning all spectators from the games this year after Japan declared a state of emergency that's meant to curb a wave of new Covid-19 infections due in part to the delta variant.

Delta is estimated by the World Health Organization to be about 55% more transmissible than alpha, the variant first found in the United Kingdom that once dominated the U.S. While current evidence shows Pfizer's is highly effective against delta in preventing severe disease and death, it may not protect as well against mild disease and spreading the disease to others, scientists say.

On Monday, Israeli officials reported a decrease in the effectiveness of the Pfizer-BioNTech vaccine in preventing infections and symptomatic illness but said it remained highly effective in preventing serious illness.

In the U.S, health officials are urging all eligible Americans to get vaccinated as quickly as possible, especially before the fall season when delta is expected to cause another surge in new coronavirus cases, particularly in places with the lowest vaccination rates.

There are about 1,000 counties in the U.S. that have Covid vaccination coverage of less than 30%, mostly located in the Southeast and Midwest, CDC Director Dr. Rochelle Walensky recently said. The agency is already seeing increasing rates of infection in those areas due to the further spread of the delta variant.

Executives from Pfizer and BioNtech have repeatedly said people will likely need a booster shot, or third dose, within 12 months of getting fully vaccinated because they expect vaccine-induced immunity to wane over time. They also said it's likely people will need to get additional shots each year.

Pfizer and BioNTech are developing booster shots and are expected to shortly seek U.S. authorization for a third dose of its vaccine.

Got a confidential news tip? We want to hear from you.

Sign up for free newsletters and get more CNBC delivered to your inbox

Get this delivered to your inbox, and more info about our products and services. 

Data is a real-time snapshot *Data is delayed at least 15 minutes. Global Business and Financial News, Stock Quotes, and Market Data and Analysis.

Read full article at USA TODAY

Pfizer Wants Approval for Third Shot

Newser 09 July, 2021 - 06:09am

(Newser) – Seeing signs that the effectiveness of its vaccine is fading, Pfizer said Thursday it will ask for approval to distribute a third dose to help fight new coronavirus variants. The company plans to ask the Food and Drug Administration for emergency use authorization next month, CNN reports. Pfizer cited findings from Israeli health officials that its vaccine's efficacy is declining as the Delta variant of the virus spreads. That agrees with the company's analysis, it said. Pfizer has begun producing the booster shot, per the Wall Street Journal, and wants to start clinical trials in August, saying in a statement that a third shot might be needed, for maximum immunity, six to 12 months after a person has become fully vaccinated.

Sunrise coronavirus updates - July 9, 2021

WTHR 09 July, 2021 - 06:09am

Business Stories